Laurence J. Blumberg
Founder at Syntimmune, Inc.
Profile
Laurence J.
Blumberg was the founder of Bioverativ Therapeutics, Inc. (founded in 1999) and Syntimmune, Inc. (founded in 2013), where he holds the title of Director.
Currently, Dr. Blumberg is the President, Chief Executive Officer & Director at Arch Oncology, Inc. since 2021.
He is also a Non-Managing Member at AFB Fund LLC and a Managing Member at Blumberg Capital Advisors LLC.
In the past, Dr. Blumberg served as a Director at Cambridge Heart, Inc. from 2006 to 2008 and as the President of Blumberg Capital Management LLC.
He also worked as a Senior Global Biotechnology Analyst at Alliance Capital Corp.
from 1994 to 1999 and as a Senior Vice President-Business Development at Kadmon Corp.
LLC.
Dr. Blumberg holds an MBA from The Trustees of Columbia University in The City of New York (conferred in 1998), an undergraduate degree from Brandeis University (conferred in 1983), and a doctorate from Temple University School of Medicine.
Laurence J. Blumberg active positions
| Companies | Position | Start |
|---|---|---|
AFB Fund LLC
 AFB Fund LLC Investment Trusts/Mutual FundsMiscellaneous AFB Fund LLC provides fund and sub-fund services. It offers general, designated, restricted and auxiliary fund services. The company is headquartered in Tenafly, NJ. | Corporate Officer/Principal | - |
| Blumberg Capital Advisors LLC | Corporate Officer/Principal | 2011-05-03 |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Founder | 2012-12-31 |
Arch Oncology, Inc.
 Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Chief Executive Officer | 2021-04-06 |
Former positions of Laurence J. Blumberg
| Companies | Position | End |
|---|---|---|
| CAMBRIDGE HEART, INC. | Director/Board Member | 2007-12-31 |
Blumberg Capital Management LLC
 Blumberg Capital Management LLC Investment ManagersFinance Blumberg Capital Management LLC is a hedge fund manager located in New York City. | President | 2007-07-30 |
Alliance Capital Corp.
 Alliance Capital Corp. Finance/Rental/LeasingFinance Alliance Capital Corp. provides equipment financing and leasing services. It offers capital, operating, TRAC lease services. The company was founded in 1995 and is headquartered in Minneapolis, MN. | Corporate Officer/Principal | - |
Kadmon Corp. LLC
 Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Founder | - |
Training of Laurence J. Blumberg
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Brandeis University | Undergraduate Degree |
| Temple University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Cambridge Heart, Inc.
 Cambridge Heart, Inc. Medical SpecialtiesHealth Technology Cambridge Heart, Inc. engages in the development and commercialization of products for the non-invasive diagnosis of cardiac disease. The company was founded by Jeffrey M. Arnold and Jordan S. Davis on January 16, 1990 and is headquartered in Tewksbury, MA. | Health Technology |
AFB Fund LLC
AFB Fund LLC Investment Trusts/Mutual FundsMiscellaneous AFB Fund LLC provides fund and sub-fund services. It offers general, designated, restricted and auxiliary fund services. The company is headquartered in Tenafly, NJ. | Miscellaneous |
| Blumberg Capital Advisors LLC | |
Bioverativ Therapeutics, Inc.
Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Health Technology |
Syntimmune, Inc.
Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Health Technology |
Blumberg Capital Management LLC
Blumberg Capital Management LLC Investment ManagersFinance Blumberg Capital Management LLC is a hedge fund manager located in New York City. | Finance |
Alliance Capital Corp.
Alliance Capital Corp. Finance/Rental/LeasingFinance Alliance Capital Corp. provides equipment financing and leasing services. It offers capital, operating, TRAC lease services. The company was founded in 1995 and is headquartered in Minneapolis, MN. | Finance |
Arch Oncology, Inc.
Arch Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Arch Oncology, Inc. develops drugs for life-threatening disorders. Its products include anti-CD47 monoclonal antibody, CD47 antisense oligonucleotide, and a small molecule CD47 inhibitor. The company was founded by William A. Frazier and Jeffrey S. Isenberg in 2006 and is headquartered in Brisbane, CA. | Commercial Services |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Laurence J. Blumberg
